Literature DB >> 33911184

The risk of developing a meningioma during and after pregnancy.

Jenny Pettersson-Segerlind1,2, Tiit Mathiesen2,3,4, Adrian Elmi-Terander1,2, Erik Edström1,2, Mats Talbäck5, Maria Feychting5, Giorgio Tettamanti6.   

Abstract

Pregnancy has been associated with diagnosis or growth of meningiomas in several case reports, which has led to the hypothesis that pregnancy may be a risk factor for meningiomas. The aim of this study was to test this hypothesis in a large population-based cohort study. Women born in Sweden 1958-2000 (N = 2,204,126) were identified and matched with the Medical Birth Register and the Cancer Register. The expected number of meningioma cases and risk ratios were calculated for parous and nulliparous women and compared to the observed number of cases. Compared to parous women, meningiomas were more common among nulliparous (SIR = 1.73; 95% CI 1.52-1.95). The number of meningioma cases detected during pregnancy was lower than the expected (SIR = 0.40; 95% CI 0.20-0.72). Moreover, no increased risk was found in the first-year post-partum (SIR = 1.04; 95% CI 0.74-1.41). Contrary to our hypothesis, there was no increased risk for diagnosing a meningioma during pregnancy or 1-year post-partum. A lower detection rate during pregnancy, may reflect under-utilization of diagnostic procedures, but the actual number of meningiomas was homogenously lower among parous than nulliparous women throughout the study period, indicating that pregnancy is not a risk factor for meningioma.

Entities:  

Year:  2021        PMID: 33911184     DOI: 10.1038/s41598-021-88742-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  41 in total

1.  Predisposing conditions and risk factors for development of symptomatic meningioma in adults.

Authors:  Brigitte Schneider; Heinke Pülhorn; Bernd Röhrig; Nikolai G Rainov
Journal:  Cancer Detect Prev       Date:  2005-09-26

2.  Risk of brain tumors associated with exposure to exogenous female sex hormones.

Authors:  Annette Wigertz; Stefan Lönn; Tiit Mathiesen; Anders Ahlbom; Per Hall; Maria Feychting
Journal:  Am J Epidemiol       Date:  2006-07-11       Impact factor: 4.897

3.  Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.

Authors:  K Korhonen; J Raitanen; J Isola; H Haapasalo; T Salminen; A Auvinen
Journal:  Cancer Causes Control       Date:  2010-08-21       Impact factor: 2.506

4.  Association of meningioma with reproductive factors.

Authors:  Eunsuk Lee; James Grutsch; Victoria Persky; Roberta Glick; Juliana Mendes; Faith Davis
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

Review 5.  Epidemiology and etiology of meningioma.

Authors:  Joseph Wiemels; Margaret Wrensch; Elizabeth B Claus
Journal:  J Neurooncol       Date:  2010-09-07       Impact factor: 4.130

6.  Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study.

Authors:  Victoria S Benson; Kirstin Pirie; Jane Green; Diana Bull; Delphine Casabonne; Gillian K Reeves; Valerie Beral
Journal:  Int J Cancer       Date:  2010-10-01       Impact factor: 7.396

7.  Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.

Authors:  Elizabeth B Claus; Lisa Calvocoressi; Melissa L Bondy; Margaret Wrensch; Joseph L Wiemels; Joellen M Schildkraut
Journal:  J Neurosurg       Date:  2012-10-26       Impact factor: 5.115

8.  Reproductive factors and risk of primary brain tumors in women.

Authors:  Gabriella M Anic; Melissa H Madden; L Burton Nabors; Jeffrey J Olson; Renato V LaRocca; Zachary J Thompson; Shitaldas J Pamnani; Peter A Forsyth; Reid C Thompson; Kathleen M Egan
Journal:  J Neurooncol       Date:  2014-04-04       Impact factor: 4.130

9.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

Review 10.  Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis.

Authors:  Victoria S Benson; Oksana Kirichek; Valerie Beral; Jane Green
Journal:  Int J Cancer       Date:  2014-11-12       Impact factor: 7.396

View more
  2 in total

1.  Pregnancy and Childbirth in Women With Meningioma.

Authors:  David R Hallan; Debarati Bhanja; Bao Y Sciscent; Casey Ryan; Michael J Gigliotti; Lekhaj C Daggubati; Catherine Caldwell; Elias Rizk
Journal:  Cureus       Date:  2022-07-31

2.  Current knowledge on spinal meningiomas: a systematic review protocol.

Authors:  Victor Gabriel El-Hajj; Jenny Pettersson Segerlind; Gustav Burström; Erik Edström; Adrian Elmi-Terander
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.